Publications

Filter by:

Pembrolizumab for the treatment of non-small-cell lung cancer

By:

Amita Patnaik, MD, FRCPC

Journal: New England Journal of Medicine (NEJM)

Published Date: April 9, 2015

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

By:

Amita Patnaik, MD, FRCPC

Journal: Lancet

Published Date: September 20, 2014

Crystal structure of Spot 14, a modulator of fatty acid synthesis

By:

William B. McKean, MD

Journal: Proc Natl Acad Sci USA

Published Date: November 2, 2010

Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent,2-methoxyestradiol

By:

Nehal Lakhani, MD, PhD

Journal: J Pharm Sci

Published Date: July 1, 2007

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.